PMC:7172841 / 4355-4608 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T28","span":{"begin":228,"end":231},"obj":"Body_part"},{"id":"T29","span":{"begin":243,"end":252},"obj":"Body_part"}],"attributes":[{"id":"A28","pred":"fma_id","subj":"T28","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A29","pred":"fma_id","subj":"T29","obj":"http://purl.org/sig/ont/fma/fma62864"}],"text":"fication might apply to patients with SRF caused by SARS-CoV-2. Results revealed that approximately one fourth of patients with SRF have MAS and that most patients suffer from immune dysregulation dominated by low expression of HLA-DR on CD14 monocytes,"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T47","span":{"begin":52,"end":60},"obj":"Disease"},{"id":"T48","span":{"begin":52,"end":56},"obj":"Disease"},{"id":"T49","span":{"begin":137,"end":140},"obj":"Disease"}],"attributes":[{"id":"A47","pred":"mondo_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A48","pred":"mondo_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A49","pred":"mondo_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"}],"text":"fication might apply to patients with SRF caused by SARS-CoV-2. Results revealed that approximately one fourth of patients with SRF have MAS and that most patients suffer from immune dysregulation dominated by low expression of HLA-DR on CD14 monocytes,"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T34","span":{"begin":243,"end":252},"obj":"http://purl.obolibrary.org/obo/CL_0000576"}],"text":"fication might apply to patients with SRF caused by SARS-CoV-2. Results revealed that approximately one fourth of patients with SRF have MAS and that most patients suffer from immune dysregulation dominated by low expression of HLA-DR on CD14 monocytes,"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T22","span":{"begin":232,"end":234},"obj":"Chemical"}],"attributes":[{"id":"A22","pred":"chebi_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"}],"text":"fication might apply to patients with SRF caused by SARS-CoV-2. Results revealed that approximately one fourth of patients with SRF have MAS and that most patients suffer from immune dysregulation dominated by low expression of HLA-DR on CD14 monocytes,"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T24","span":{"begin":176,"end":196},"obj":"Phenotype"}],"attributes":[{"id":"A24","pred":"hp_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/HP_0002958"}],"text":"fication might apply to patients with SRF caused by SARS-CoV-2. Results revealed that approximately one fourth of patients with SRF have MAS and that most patients suffer from immune dysregulation dominated by low expression of HLA-DR on CD14 monocytes,"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T114","span":{"begin":52,"end":62},"obj":"SP_7"},{"id":"T115","span":{"begin":176,"end":182},"obj":"UBERON:0002405;GO:0006955"},{"id":"T116","span":{"begin":183,"end":196},"obj":"GO:0006955"},{"id":"T117","span":{"begin":214,"end":224},"obj":"GO:0010467"},{"id":"T118","span":{"begin":228,"end":231},"obj":"PR:000029150"},{"id":"T119","span":{"begin":238,"end":242},"obj":"PR:000001889"},{"id":"T120","span":{"begin":243,"end":252},"obj":"CL:0000576"}],"text":"fication might apply to patients with SRF caused by SARS-CoV-2. Results revealed that approximately one fourth of patients with SRF have MAS and that most patients suffer from immune dysregulation dominated by low expression of HLA-DR on CD14 monocytes,"}

{"project":"LitCovid-PubTator","denotations":[{"id":"185","span":{"begin":238,"end":242},"obj":"Gene"},{"id":"189","span":{"begin":24,"end":32},"obj":"Species"},{"id":"190","span":{"begin":52,"end":62},"obj":"Species"},{"id":"191","span":{"begin":114,"end":122},"obj":"Species"},{"id":"192","span":{"begin":155,"end":163},"obj":"Species"},{"id":"200","span":{"begin":38,"end":41},"obj":"Disease"},{"id":"201","span":{"begin":128,"end":131},"obj":"Disease"}],"attributes":[{"id":"A185","pred":"tao:has_database_id","subj":"185","obj":"Gene:929"},{"id":"A189","pred":"tao:has_database_id","subj":"189","obj":"Tax:9606"},{"id":"A190","pred":"tao:has_database_id","subj":"190","obj":"Tax:2697049"},{"id":"A191","pred":"tao:has_database_id","subj":"191","obj":"Tax:9606"},{"id":"A192","pred":"tao:has_database_id","subj":"192","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"fication might apply to patients with SRF caused by SARS-CoV-2. Results revealed that approximately one fourth of patients with SRF have MAS and that most patients suffer from immune dysregulation dominated by low expression of HLA-DR on CD14 monocytes,"}